Safety Study of Etripamil Nasal Spray for Patients With Paroxysmal Supraventricular Tachycardia. NODE-303
NCT04072835
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
1116
Enrollment
OTHER
Sponsor class
Conditions
Paroxysmal Supraventricular Tachycardia
Interventions
DRUG:
Etripamil NS
Sponsor
Milestone Pharmaceuticals Inc.
Collaborators
[object Object]